FCPM III SERVICES B.V.
CIK 2013410 · View on SEC EDGAR ↗
- Portfolio value
- $722.2M
- Positions
- 10
- As of
- March 31, 2026 Data as of Q1 2026
#2,789 of 8,643 by 13F value · top 32.3%
Portfolio value QoQ: +45.4% 13F does not disclose cash
- Top 10 holdings weight
- 99.88%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 10
- Effective number of positions
- 6.1
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $28,781,803 · sells $0
Median holding: 4.0 quarters Tracked Q4 2024–Q2 2026 · 78.6% still held
- New positions
- 1
- Increased
- 0
- Decreased
- 0
- Closed
- 1
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
99.9%
Other/Unmapped
0.1%
Full portfolio 11 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $157,521,567 | 28.07% | 4,648,025 | $8,738,287 | |||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $115,634,176 | 20.60% | 3,226,400 | $50,041,464 | |||
| VOR Vor Biopharma Inc. - Common Stock | $75,800,487 | 13.51% | 4,117,354 | $2,346,892 | |||
| GLTO Galecto, Inc. - Common Stock | $63,490,410 | 11.31% | 2,441,000 | $268,510 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $31,679,678 | 5.64% | 1,426,370 | $5,819,590 | |||
| REPL Replimune Group, Inc. - Common Stock | $31,088,634 | 5.54% | 2,808,368 | $9,604,619 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $30,201,336 | 5.38% | 1,677,852 | $-620,805 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $28,781,803 | 5.13% | 4,053,775 | Up ×1 | |||
| BCYC Bicycle Therapeutics plc - American Depositary Shares | $14,706,143 | 2.62% | 3,468,430 | $-1,387,372 | |||
| ENGN enGene Holdings Inc. - Common Stock | $11,657,366 | 2.08% | 6,738,362 | $-34,230,879 | |||
| ENGNW enGene Holdings Inc. - Warrants | $696,651 | 0.12% | 2,403,072 | $-5,383,121 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| AURA | $28,781,803 | 4,053,775 | 5.13% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| MPLT | Price move only | +0 | +$50.0M |
| ENGN | Price move only | +0 | -$34.2M |
| REPL | Price move only | +0 | +$9.6M |
| NAMS | Price move only | +0 | +$8.7M |
| DYN | Price move only | +0 | +$5.8M |
| VOR | Price move only | +0 | +$2.3M |
| BCYC | Price move only | +0 | -$1.4M |
| CBIO | Price move only | +0 | -$621K |
| GLTO | Price move only | +0 | +$269K |
1 position hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| RAPT | March 31, 2026 | 1,833,333 | $62,094,989 | No longer tracked |
| ATXS | Dec. 31, 2025 | 4,107,537 | $29,902,869 | No longer tracked |
| ACHL | March 31, 2025 | 2,390,050 | $2,748,558 | No longer tracked |